According to Aldeyra Therapeutics 's latest financial reports the company's total liabilities are NZ$48.79 Million. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | NZ$59.58 M | 32.06% |
2023-12-31 | NZ$45.11 M | -5.41% |
2022-12-31 | NZ$47.69 M | 18.9% |
2021-12-31 | NZ$40.11 M | 21.4% |
2020-12-31 | NZ$33.04 M | -18.88% |
2019-12-31 | NZ$40.73 M | 222.5% |
2018-12-31 | NZ$12.63 M | 96.14% |
2017-12-31 | NZ$6.44 M | 26.1% |
2016-12-31 | NZ$5.1 M | 5.09% |
2015-12-31 | NZ$4.86 M | 52.14% |
2014-12-31 | NZ$3.19 M | -53.51% |
2013-12-31 | NZ$6.87 M | -79.16% |
2012-12-31 | NZ$32.98 M | 892.52% |
2011-12-31 | NZ$3.32 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Regeneron Pharmaceuticals REGN | NZ$13.44 B | 27,462.16% | ๐บ๐ธ USA |